FDA Investigator Timothy P Lafave
Timothy P Lafave has conducted inspections on 263 sites in 1 countries as of 13 Jan 2015. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
263
Last Inspection Date:
13 Jan 2015
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Timothy P Lafave:
Abby Lmozeke Baker,
Adam J Taylor,
Ademola O Daramola,
Aleta T Flores,
Alexandra B Pitkin,
Aliza Chalapong Asawesna,
Allen F Hall,
Amy A Johnson,
Ana Djurdjevic,
Ana S Cabrera,
Angelina M Albert,
Annette Melendez,
Anthony G Emerson,
April P Shaw,
Armando Chavez, MS,
Barbara D Wright,
Barbara J Rincon,
Benjamin S Liao,
Beverly A Thomas,
Bichsa T Tran,
Bonnie I Needleman,
Brandon L Blakely,
Brentley S Collins,
Brian P Putz,
Brien C Fox,
Bryce A May,
Bush,
Carla J Lundi,
Carol B Czerniak,
Cathleen A Carr Sharpe,
CDR Cecily Jones,
Celena Ngo,
Celeta S Coves,
Charles D Boison,
Christine I Shaw,
Comyar Shoghi,
Courtney N Long,
Creighton T Tuzon,
Dana M Klimavicz,
Daniel J Lahar,
Daniel R Solis,
Daniel W Cline,
Darin J Files,
Darrin E Davis,
David G Whitman,
David Y Hernandez,
Davis,
Deborah A Greco,
Decarlos A Gomez,
Deidre R Edwards,
Dejon N Harris,
Diana L Ayala,
Diana M Rand,
Diane Cvan Leeuwen,
Don A Leeseberg,
Donna Ltartaglino Besone,
Donna Mwilliams Hill, PhD,
Doretha M Tonkins,
Doretha M Wilson,
Dylan R Jock,
Ellen N Stewart,
Elmina E Akwo,
Eric Zhu,
Erma Zaimova,
Francisco,
Gabriel Craig,
Gabriel M Guevarra,
Garciam,
Garrad R Poole,
Gene D Arcy,
Geoffrey M Leist,
Gerald T O'connor,
Gloria A Milster,
Grace P Santos,
Greg K Keshishyan,
Hanna L Potter,
Herminio C Francisco,
Humberto Z Gomez,
Jaclyn N Munsch,
Jacobitz,
Jacqueline M Bowling,
James A Barreto,
James P Stallings,
Janet Pulver,
Jazmine M Welcher,
Jeff M Uriarte,
Jennifer Crumb,
Jennifer L Blanck,
Jennifer L Custodio,
Jennifer M Foley,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Joey V Quitania,
John A Daubenspeck,
John A Gonzalez,
John A Iwen,
Joseph C Yen,
Joseph S Fanelli,
Joshua E Yao,
Judy C Nepsa,
Julia Ventura,
Julian C Hanson,
Ka L Wong,
Karen J Bak,
Kathleen B Swat,
Kelley,
Kelvin Cheung,
Kelvin X Sanders,
Kenneth S Boehnen,
Kevin Lee,
Kevin T Gerrity,
Kimberly M Lichter,
Lakecha N Lewis,
Lam,
Lanita F Kelley,
Lauren E Swantko,
Lauren M Lilly, PhD,
Laurissa S Flowers,
Lawrence H Howell,
Leticia I Romero,
Lilly O Barton,
Lisa Shin,
Loretta J Jordan,
Lourdes M Countee,
Marco S Esteves,
Marcus F Yambot,
Margo C Jones,
Mark C Saale,
Mary Ewilkerson Brinsko,
Mary T Carden,
Matthew J Gretkierewicz,
Maxyne T Lam,
Mei Chen Mu,
Melsomar R Ramos,
Mendoza O Wallace,
Michael A Blaine,
Michael D Garcia,
Michael F Schuette,
Michelle J Hines,
Minh D Phan,
Monica J Wilkins,
Monica R Maxwell,
Nancy E Byerly,
Ngoc T Le,
Nianna C Burns,
Nikisha M Bolden,
Olusegun J Ajayi,
Paul M Chefor,
Phal K Chhun,
Phillip L Toy,
Rachel V Leimbach,
Raymond W Brullo,
Richard L Bartlett,
Richard T Riggie,
Richard W Tubb,
Robert C Hoover,
Robert S Sweeton,
Roger D Gawne,
Romero,
Ruben G Abrajano,
Sara Jdent Acosta,
Sarah A Hassas,
Sarah Forney,
Scott K Zika,
Sean P Desbrow,
Shaquenta Y Perkins,
Sharon S Ho,
Sherri N Rohlf, MD,
Sonia R Peterson,
Sonya L Karsik, RAC,
Sparky L Bartee,
Steven E Porter, Jr,
Sundy V Sedwick,
Sunitha K Rajaram, PhD,
Susan M North,
Sydney S Taylor,
Tania Y Hall,
Tanya E Malais,
Tawny L Colling,
Terrance L Thomas,
Terri L Jones,
Thanh B Tran,
Thanh M Andrews,
Thomas R Beilke,
Tonia L Sawyer,
Tony J Wu,
Traci M Armand,
Travis R Hunt,
Trudy R Papson,
Trushani T Desai,
Vanessa R Muller,
Victor H Loo,
Vien Q Le,
Virgilio F Pacio, CSO,
Yen Tso Kuo,
Yvette E Guillermo,
Yvette Mlacour Davis,
Yvonne C Wilkes,
Yvonne T Lacour,
Zachary Ryan Harris
Timothy P Lafave's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| August, 2001 | FDA 483 | Biomat USA, Inc. - Form 483, 2001-08-15 |
| June, 2010 | EIR | HemaCare Corp Dba USC Blood Center - University Village - EIR, 2010-06-30 |
| February, 2003 | FDA 483 | American National Red Cross, (The), Nat'l Testing Laboratory - Form 483, 2003-02-28 |
| September, 2000 | EIR | American National Red Cross - EIR, 2000-09-22 |
| April, 2000 | FDA 483 | AMERICAN RED CROSS BLOOD SERVICES - Form 483, 2000-04-05 |
| July, 2000 | EIR | Biomat USA, Inc. - EIR, 2000-07-05 |
| July, 2000 | FDA 483 | Biomat USA, Inc. - Form 483, 2000-07-05 |
| April, 2010 | FDA 483 | Greenline Laboratories - Form 483, 2010-04-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more